胰腺癌每日在线自适应MRI引导立体定向放疗的剂量学获益与实际操作陷阱
10例胰腺癌患者接受33-40 Gy/5次SBRT,比较每日在线自适应MRI引导放疗与非自适应计划的剂量学差异。自适应计划PTV100均值90%优于非自适应80.4%(P=.0008),十二指肠Dmax 38 Gy达标次数43 vs 32(P=.022)。需注意评估治疗区附近所有OAR。
要点
- 自适应计划PTV100均值90% vs 非自适应80.4%(P=.0008)
- 十二指肠Dmax 38 Gy达标:自适应43次 vs 非自适应32次(P=.022)
- 非自适应计划中胃体积分次间增大会增加胃和十二指肠剂量
核心结论
- MRI引导在线自适应放疗改善胰腺SBRT的靶区覆盖和OAR保护。
- 该获益部分来自减轻胃体积的分次间变化。
- 必须谨慎评估治疗区附近所有OAR。
研究设计与样本
- 10例胰腺癌患者接受SBRT,剂量33至40 Gy分5次。
- 处方要求PTV100的90%覆盖率。
- 每次分次成像后重新勾画正常解剖并重算原计划为非自适应计划,再优化生成自适应计划并归一化至PTV100 90%覆盖。
- 比较自适应与非自适应计划的靶区和OAR剂量。
主要发现
- PTV100均值自适应90% vs 非自适应80.4%(范围46%-97%),P=.0008。
- 十二指肠Dmax 38 Gy达标:自适应43次 vs 非自适应32次,P=.022。
- PTV100≥90%且所有OAR达标:自适应28次 vs 非自适应仅3次。
- 非自适应计划中胃体积分次间增大与胃V33(P=.004)、胃Dmax(P=.009)、十二指肠V33(P=.021)、十二指肠Dmax(P=.105)相关。
- 自适应计划中胃体积与OAR剂量无相关性。
关键数值与推荐
- 处方剂量33至40 Gy分5次,PTV100覆盖率90%。
- 十二指肠Dmax目标为38 Gy。
- 脊髓Dmax目标为20 Gy,大肠Dmax目标为38 Gy。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Magnetic resonance imaging guided (MRI-g) radiation therapy provides visualization of the target and organs at risk (OARs), allowing for daily online adaptive radiation therapy (OART). We hypothesized that MRI-g OART would improve OAR sparing and target coverage in patients with pancreatic cancer treated with stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: Ten patients received pancreas SBRT to a dose of 33 to 40 Gy in 5 fractions. The dose was prescribed to 90% coverage of the planning target volume at 100% isodose (PTV100). After each fraction's setup magnetic resonance imaging scan, the target position was aligned by 3-dimensional shifts, the normal anatomy was recontoured, and the original radiation therapy plan was recalculated to create a nonadaptive plan. A reoptimized (adaptive) plan was then generated for each fraction and renormalized to 90% coverage of PTV100. Target and OAR doses between nonadaptive and adaptive plans were compared to assess the dosimetric impact of daily adaptation. RESULTS: The PTV100 mean for adaptive and nonadaptive techniques was 90% and 80.4% (range, 46%-97%), respectively (P = .0008). Point maximum (Dmax) 38 Gy duodenum objectives were met in 43 adaptive fractions compared with 32 nonadaptive fractions (P = .022). Both PTV100 ≥90% and all OAR objectives were achieved in 28 adaptive fractions compared with only 3 nonadaptive fractions. For nonadaptive plans, interfraction increases in stomach volume correlated with higher stomach V33 (P = .004), stomach Dmax (P = .009), duodenum V33 (P = .021), and duodenum Dmax (P = .105). No correlation was observed between stomach volume and OAR doses for adaptive plans. OART plans with Dmax violations of the spinal cord (20 Gy) in 4 fractions and large bowel (38 Gy) in 5 fractions were identified (although not delivered). CONCLUSIONS: MRI-g OART improves target coverage and OAR sparing for pancreas SBRT. This benefit partially results from mitigation of interfraction variability in stomach volume. Caution must be exercised to evaluate all OARs near the treatment area.
引用
- El-Bared N, Portelance L, Spieler BO, et al. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer. Pract Radiat Oncol. 2018. PMID: 30149192. doi:10.1016/j.prro.2018.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。